Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The good and bad...IMO

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Dec 02, 2021 5:14pm

196 Views

Post# 34192271

RE:RE:RE:The good and bad...IMO

Somehow a 98% valuation discount, using their own projections, is a product of the biotech index being down 30%. Okay, makes perfect sense for a struggling pre clinical company with nothing on the table. Not good enough for a confirmatory P3 company trialing a treatment that has been used on over 300K people globally and other multiple FDA approvals. Weak, pathetically weak.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide